Takeda to Start Sales and Marketing Operation in Portugal
OSAKA, Japan & LONDON, May 7, 2009 – Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”) and its wholly-owned UK-based subsidiary for overseeing pan-European sales & marketing, Takeda Pharmaceutical Europe Limited (London, UK, “TPEU”) have jointly announced the start of their own wholly owned sales and marketing operation in Portugal, Takeda Farmacêuticos Portugal, Unipessoal, Lda (Lisbon, Portugal, “Takeda Portugal”). This represents the latest move in Takeda’s initiative to enhance its business infrastructure in Europe.
Takeda Portugal started to provide Glustin® (generic name: pioglitazone HCl, known in Japan, U.S. and other European markets as Actos™) via wholesalers on a demand-only basis in September last year, and now plans to start its sales and marketing operations within the next few months.
“We are delighted to be expanding into Portugal, and along with the countries where we already have our own sales and marketing operations, we will be now be directly covering most of Western Europe, namely France, UK, Italy, Germany, Austria, Switzerland, Spain and the Republic of Ireland,” said Eric Brunn, CEO of TPEU. “We will actively introduce products from our portfolio, so that they will help many more patients suffering from a variety of diseases in Portugal.”
“The establishment of Takeda Portugal’s operations represents the fourth geographic expansion for Takeda this year, following Canada, Spain and the Republic of Ireland,” said Alan MacKenzie, Executive Vice President (EVP) International Operations, Takeda Pharmaceuticals International, Inc. “Takeda’s expansion efforts in the Americas, Europe and Asia will play a significant role in helping us realize our vision of becoming a leading pharmaceutical company with highly integrated global operations.”
About Takeda Farmacêuticos Portugal, Unipessoal, Lda
|Name:||Takeda Farmacêuticos Portugal, Unipessoal, Lda|
|Capital Stock:||Euro 2.5 million (as of May 7, 2009)|
About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, www.takeda.com.
About Takeda Pharmaceuticals Europe Limited (TPEU)
Based in London, UK, TPEU supports and leads the overall business activities of Takeda’s marketing activities in nine countries in Europe[ * ] by promoting pan-European sales and marketing strategies.
|[ * ]||Laboratoires Takeda (France)|
|Takeda UK Limited (UK and the Republic of Ireland)|
|Takeda Italia Farmaceutici S.p.A. (Italy)|
|Takeda Pharma GmbH (Germany),|
|Takeda Pharma Ges.m.b.H (Austria)|
|Takeda Pharma AG (Switzerland),|
|Takeda Farmacéutica España S.A. (Spain),|
|Takeda Farmacêuticos Portugal, Unipessoal, Lda (Portugal)|
Posted: May 2009